These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

377 related items for PubMed ID: 19079439

  • 1. Cardiovascular disease risk factor assessment and management in gout: an analysis using guideline-based electronic clinical decision support.
    Colvine K, Kerr AJ, McLachlan A, Gow P, Kumar S, Ly J, Wiltshire C, Robinson E, Dalbeth N.
    N Z Med J; 2008 Nov 07; 121(1285):73-81. PubMed ID: 19079439
    [Abstract] [Full Text] [Related]

  • 2. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record.
    Rabinowitz I, Tamir A.
    Eur J Cardiovasc Prev Rehabil; 2005 Feb 07; 12(1):56-62. PubMed ID: 15703507
    [Abstract] [Full Text] [Related]

  • 3. The Bold Promise Project: a system change in primary care to support cardiovascular risk screening.
    Sinclair G, Kerr A.
    N Z Med J; 2006 Nov 17; 119(1245):U2312. PubMed ID: 17146487
    [Abstract] [Full Text] [Related]

  • 4. [Hypertension management in general practice in Iceland].
    Jensdóttir JO, Sigurethsson EL, Thornorgeirsson G.
    Laeknabladid; 2006 May 17; 92(5):375-80. PubMed ID: 16741320
    [Abstract] [Full Text] [Related]

  • 5. Assessing Māori/non-Māori differences in cardiovascular disease risk and risk management in routine primary care practice using web-based clinical decision support: (PREDICT CVD-2).
    Riddell T, Jackson RT, Wells S, Broad J, Bannink L.
    N Z Med J; 2007 Mar 02; 120(1250):U2445. PubMed ID: 17339901
    [Abstract] [Full Text] [Related]

  • 6. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice.
    Wells S, Furness S, Rafter N, Horn E, Whittaker R, Stewart A, Moodabe K, Roseman P, Selak V, Bramley D, Jackson R.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr 02; 15(2):173-8. PubMed ID: 18391644
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular risk management at a Maori-led Primary Health Organisation--findings from a cross-sectional audit.
    Peiris D, Murray J, Scully D, Tilakawardene V, Hetaraka-Stevens L, Stewart T, Patel A.
    N Z Med J; 2008 Nov 07; 121(1285):35-46. PubMed ID: 19079435
    [Abstract] [Full Text] [Related]

  • 8. Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1).
    Bannink L, Wells S, Broad J, Riddell T, Jackson R.
    N Z Med J; 2006 Nov 17; 119(1245):U2313. PubMed ID: 17146488
    [Abstract] [Full Text] [Related]

  • 9. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA, Wells S, Scragg RK, Jackson R.
    N Z Med J; 2008 Sep 05; 121(1281):49-57. PubMed ID: 18797484
    [Abstract] [Full Text] [Related]

  • 10. [Guideline 'Cardiovascular Risk Management'].
    Burgers JS, Simoons ML, Hoes AW, Stehouwer CD, Stalman WA.
    Ned Tijdschr Geneeskd; 2007 May 12; 151(19):1068-74. PubMed ID: 17552415
    [Abstract] [Full Text] [Related]

  • 11. The impact of New Zealand CVD risk chart adjustments for family history and ethnicity on eligibility for treatment (PREDICT CVD-5).
    Wells S, Kerr A, Broad J, Riddell T, Kenealy T, Jackson R.
    N Z Med J; 2007 Sep 07; 120(1261):U2712. PubMed ID: 17853933
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular protection paradigms: is change on the horizon?
    Papademetriou V.
    Rev Cardiovasc Med; 2007 Sep 07; 8(4):200-13. PubMed ID: 18192943
    [Abstract] [Full Text] [Related]

  • 13. Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
    Keenan RT, Pillinger MH.
    Bull NYU Hosp Jt Dis; 2009 Sep 07; 67(3):285-90. PubMed ID: 19852752
    [Abstract] [Full Text] [Related]

  • 14. Challenges for the management of hypertension in low-resource settings.
    Mendis S.
    Ethn Dis; 2003 Sep 07; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [Abstract] [Full Text] [Related]

  • 15. [Prevention in cardiovascular pathology].
    Chamontin B, Amar J.
    Therapie; 2001 Sep 07; 56(2):119-24. PubMed ID: 11471362
    [Abstract] [Full Text] [Related]

  • 16. Are at-risk New Zealand women receiving recommended cardiovascular preventive therapy?
    Bupha-Intr O, Rose SB, Lawton BA, Elley CR, Dowell AC.
    N Z Med J; 2010 Feb 19; 123(1309):26-36. PubMed ID: 20186240
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the possibility to classify patients according to cholesterol guideline screening criteria using routinely recorded electronic patient record data.
    Van Wyk JT, Van Wijk MA.
    Stud Health Technol Inform; 2002 Feb 19; 93():39-46. PubMed ID: 15058412
    [Abstract] [Full Text] [Related]

  • 18. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension.
    Ruilope LM, Segura J.
    Clin Ther; 2005 Oct 19; 27(10):1658-68. PubMed ID: 16330303
    [Abstract] [Full Text] [Related]

  • 19. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice.
    Di Martino M, Degli Esposti L, Filigheddu F, Veronesi C, Salerno G, Saragoni S, Glorioso N, Didoni G, Degli Esposti E.
    J Hum Hypertens; 2007 Jan 19; 21(1):53-9. PubMed ID: 17036042
    [Abstract] [Full Text] [Related]

  • 20. The burden of modifiable cardiovascular risk factors in the coronary care unit by age, ethnicity, and socioeconomic status--PREDICT CVD-9.
    Kerr AJ, McLachlan A, Furness S, Broad J, Riddell T, Jackson R, Wells S.
    N Z Med J; 2008 Nov 07; 121(1285):20-33. PubMed ID: 19079434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.